BPC-157 sits in the S0 "non-approved substances" class of the World Anti-Doping Agency Prohibited List. For anyone who competes under anti-doping rules, that classification is effectively the whole answer: banned at all times, in and out of competition, with intent no defense. Here is what S0 means, why BPC-157 ended up there, and what it costs a tested athlete.
The Short Answer
If you are subject to anti-doping testing, BPC-157 is a problem. Not a gray area, not a "check with your coach" situation.
The U.S. Anti-Doping Agency states directly that BPC-157 is prohibited under the WADA Prohibited List in the S0 Unapproved Substances category. The Department of Defense's Operation Supplement Safety program says the same, describing BPC-157 as listed in class S0 on WADA's Prohibited List and as an unapproved drug rather than a dietary ingredient.
What S0 Actually Means
Most classes on the Prohibited List are pharmacological. S1 covers anabolic agents, S2 covers peptide hormones and growth factors, S3 covers beta-2 agonists. Those classes exist because the substances inside them share a mechanism.
S0 is a status category instead. It captures any pharmacological substance not addressed elsewhere on the List that has, in WADA's wording, "no current approval by any governmental regulatory health authority for human therapeutic use." Drugs in development, discontinued drugs, designer compounds, and veterinary-only substances all fall inside it.
So S0 does not require WADA to demonstrate that a substance enhances performance. Membership follows from regulatory status alone. That is the part most athletes get wrong.
Why BPC-157 Lands There Automatically
BPC-157 is a synthetic 15-amino-acid peptide that has never been granted marketing authorization for human therapeutic use by any regulator anywhere. It is studied, discussed, and widely sold, but it has never completed the trial process that produces an approved human indication. That is the entire qualification for S0.
Which is why the common defenses fail. "There is no proof it improves performance" is irrelevant, because S0 does not ask that question. "It was prescribed by a licensed provider" is also irrelevant, because compounding is not regulatory approval of a drug for a human indication. Route of administration changes nothing either.
"At All Times" Is Not a Technicality
Some Prohibited List classes are restricted only in-competition. S0 is not one of them. It is prohibited at all times, out-of-competition included. Under the World Anti-Doping Code, samples can also be stored and re-analyzed later as detection methods improve.
For an athlete in a registered testing pool, that means unannounced testing during the off-season, during rehabilitation, during a training block months from any event. The common mental model, that off-season use is fine as long as the substance has cleared by race day, does not apply to an at-all-times prohibition. Presence in a sample collected at any point is a violation.
Strict Liability: Intent Is Not a Defense
Anti-doping operates on strict liability. Athletes are responsible for what is found in their samples, whether or not they intended to take it, knew they had taken it, or were told by someone they trusted that it was fine.
This is where BPC-157 gets genuinely dangerous, because it does not only appear as an obvious injectable. Operation Supplement Safety has flagged BPC-157 turning up in health and wellness products, where a buyer scanning a label may not connect an ingredient name to a prohibited substance. An athlete can encounter it without ever deciding to use it.
The defense is unglamorous: read full ingredient panels rather than front-of-bottle claims, treat "research peptide" labeling as a hard stop, use third-party certified supplement programs, and check any compound through your anti-doping organization first.
What About a Therapeutic Use Exemption?
A Therapeutic Use Exemption (TUE) lets an athlete with a diagnosed medical condition use an otherwise prohibited substance. TUE criteria generally require that the substance is the indicated treatment for that condition and that no reasonable permitted alternative exists.
Apply that to an S0 substance and the difficulty is structural. A compound with no approved human indication anywhere is, by definition, not the indicated treatment for anything. Do not assume a TUE is available here. If you think your case is exceptional, take it to your national anti-doping organization or international federation, in writing, before any use.
Who Is Actually Subject to These Rules
Most adults training in a commercial gym are not under any anti-doping jurisdiction. Nobody is going to knock on their door at 6am with a collection kit. If you have ever signed a membership form referencing anti-doping rules, though, assume you are in scope until your governing body confirms otherwise.
But the boundary catches more people than they expect: anyone holding a competition license with a national governing body, collegiate athletes under NCAA rules, masters and age-group competitors in sanctioned events, athletes on Olympic and Paralympic pathways, and competitors in leagues and combat sports organizations that run their own banned lists. Military service members sit under separate service policies on unapproved substances.
The FDA Question, and Why It Does Not Change the WADA Answer
Recent FDA news around BPC-157 is being widely misread. On July 23-24, 2026, the FDA's Pharmacy Compounding Advisory Committee voted to recommend adding BPC-157 to the 503A Bulks List (8 in favour, 6 against, 1 abstention), against FDA staff's own pre-meeting recommendation not to add it.
PCAC recommendations are advisory and non-binding. FDA must complete notice-and-comment rulemaking, which can take 12 months or more. Nothing has changed yet in what may lawfully be compounded. BPC-157 is not approved, not newly legal, and not newly available.
Now the part that matters for athletes: even completed FDA rulemaking would not change WADA status. These are separate systems. The FDA regulates drugs and compounding in the United States. WADA maintains an international anti-doping list on its own annual cycle and answers to sport governance, not to any national drug regulator. Bulk-substance eligibility for pharmacy compounding is not a marketing authorization for a human therapeutic indication, which is the specific thing S0 turns on.
Reading a favorable FDA development as anti-doping clearance is a category error that could cost an athlete their eligibility. For more on what the PCAC vote does and does not mean, see our BPC-157 patient guide.
If You Are Not Subject to Anti-Doping Testing
This section is not for tested athletes. If you compete under anti-doping rules, the answer above stands.
For adults with no anti-doping obligations, the questions are clinical rather than regulatory: what the evidence base shows, what the open safety questions are, and whether it is appropriate for your history at all. Our side effects and safety overview covers the contraindications a provider will ask about.
BPC-157 is a compounded research peptide and is not FDA-approved for any human use. It is available only by prescription after review by a licensed provider, and approval is never guaranteed. Individual results vary.
If that describes you, you can start a short online visit. Please do not start one if you are subject to anti-doping testing.
Frequently Asked Questions
Is BPC-157 banned by WADA?
Yes. BPC-157 is prohibited under the World Anti-Doping Agency Prohibited List in class S0, non-approved substances. USADA and the Department of Defense's Operation Supplement Safety program both state this directly. S0 substances are prohibited at all times, in and out of competition.
What does S0 mean on the WADA Prohibited List?
S0 covers any pharmacological substance not addressed elsewhere on the List that has no current approval by any governmental regulatory health authority for human therapeutic use. Because it is a regulatory-status category, WADA does not need to show that a substance enhances performance for it to qualify.
Would a prescription from a licensed provider protect a tested athlete?
No. A compounded prescription is not regulatory approval of a drug for a human indication, and anti-doping rules operate on strict liability. Presence of a prohibited substance in a sample is a violation regardless of how it was obtained. An S0 substance is also a structurally poor fit for Therapeutic Use Exemption criteria.
Did the 2026 FDA compounding vote change BPC-157's status for athletes?
No. On July 23-24, 2026, the FDA's Pharmacy Compounding Advisory Committee voted to recommend adding BPC-157 to the 503A Bulks List (8 in favour, 6 against, 1 abstention), against FDA staff's own pre-meeting recommendation not to add it. That recommendation is advisory and non-binding, FDA must still complete notice-and-comment rulemaking that can take 12 months or more, and nothing has changed yet in what may lawfully be compounded. FDA action also would not change WADA status, because these are separate systems.
Am I subject to anti-doping rules if I only compete recreationally?
That depends on your governing body, not on how seriously you take the sport. Collegiate athletes, license holders with national federations, masters competitors in sanctioned events, and members of leagues with their own banned lists can all be in scope. Confirm with your governing body rather than assuming.
Can BPC-157 be detected in a drug test?
Anti-doping laboratories develop and refine detection methods for listed peptides over time, and under the World Anti-Doping Code samples can be stored and re-analyzed later. For a listed substance, the only reliable protection is not having it in your system.
Always confirm a substance's status with your own anti-doping organization before use. WADA's current list is published at wada-ama.org.
TelosRX is LegitScript-certified. BPC-157 is a compounded research peptide and is not FDA-approved for any human use. Compounded medications are prepared under federal compounding regulations. Prescription is available only after review by a licensed provider; approval is not guaranteed. Individual results vary. This article is educational and is not medical, legal, or anti-doping advice. Athletes subject to anti-doping rules should consult their governing body. TelosRX operates as an online-first, asynchronous telehealth service.
Learn more about BPC-157 at TelosRX.